Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» solid tumors
solid tumors
Takeda to buy GammaDelta to accelerate allogeneic cell therapies development
Pharmaceutical Business Review
Thu, 10/28/21 - 10:37 am
Takeda
GammaDelta Therapeutics
M&A
allogeneic cells
solid tumors
Xilio Therapeutics goes public as biopharma IPOs rumble forward in Q4
Endpoints
Fri, 10/22/21 - 12:02 pm
Xilio Therapeutics
IPOs
solid tumors
Triumvira is Creating a Different Picture for Cancer Patients
BioSpace
Wed, 09/22/21 - 11:36 pm
Triumvira
CAR-T
cancer
solid tumors
Merck KGaA entrusts secretive startup with a mid-stage cancer drug targeting master signaling pathway
Endpoints
Wed, 09/8/21 - 11:03 am
Merck KGaA
M2698
Diaccurate
solid tumors
A year after a death and accompanying trial hold, Poseida hopes for reprieve with early solid tumor CAR-T data
Fierce Biotech
Tue, 08/31/21 - 11:05 am
Poseida Therapeutics
clinical trials
patient deaths
solid tumors
CAR-T
FDA Gives OK for Viracta’s Phase Ib/II Trial of Oral Combo in Epstein-Barr Virus Tumors
BioSpace
Wed, 07/21/21 - 08:50 pm
Viracta Therapeutics
clinical trials
solid tumors
EBV
A pair of former MIT researchers think they've unlocked the next generation of mRNA using synbio 'logic circuits'
Endpoints
Wed, 06/23/21 - 10:58 am
Strand Therapeutics
funding
MRNA
solid tumors
immuno-oncology
MIT
Elevation files for $100M IPO to fund tumor-agnostic candidate
Fierce Biotech
Mon, 06/7/21 - 11:11 am
Elevation Oncology
IPOs
Merrimack Pharmaceuticals
solid tumors
#ASCO21: Eli Lilly-partnered Merus reveals new data for NRG1 fusion cancers including pancreatic and NSCLC
Endpoints
Sat, 06/5/21 - 02:17 pm
ASCO 2021
Merus
Eli Lilly
clinical trials
solid tumors
GSK-backed Lyell Immunopharma, fresh off a near $500M cash injection, guns for a $150M IPO
Fierce Biotech
Wed, 05/26/21 - 11:16 am
Lyell Immunopharma
GSK
IPOs
funding
solid tumors
Researchers in biotech, academia and Big Pharma are offering puzzle pieces to crack CAR-T for solid tumors. Will they ever snap together?
Endpoints
Wed, 05/26/21 - 11:01 am
R&D
solid tumors
CAR-T
Xilio inks Merck deal to run checkpoint inhibitor combo trial
Fierce Biotech
Tue, 05/25/21 - 11:15 am
Xilio Therapeutics
Merck
Keytruda
XTX101
clinical trials
solid tumors
Compass inks Trigr takeover to land clinical-phase bispecific
Fierce Biotech
Fri, 05/14/21 - 11:04 am
Compass Therapeutics
bispecific antibodies
M&A
Trigr Therapeutics
solid tumors
Trillium unveils CD47 clinical research priorities as investors await solid tumor data
Fierce Biotech
Wed, 04/28/21 - 10:52 am
Trillium Therapeutics
CD47
solid tumors
oncology
cancer
Stealthy biotech Janux nabs $125M and joins chase to direct T cells to solid tumors
MedCity News
Wed, 04/21/21 - 11:19 pm
Janux Therapeutics
R&D
solid tumors
Bluebird, PsiOxus show oncolytic virus boosts CAR-T in solid tumors
Fierce Biotech
Wed, 04/14/21 - 09:30 am
Bluebird Bio
PsiOxus
CAR-T
solid tumors
Zentalis keeps the heat on AstraZeneca with early WEE1 data showing a group of 'exceptional' responders
Endpoints
Sun, 04/11/21 - 11:49 pm
Zentalis
ZN-c3
solid tumors
AACR
Sanofi drops 'intriguing' data on rival to Bristol Myers' bempeg
Fierce Biotech
Fri, 04/9/21 - 10:37 am
Sanofi
solid tumors
Bristol Myers Squibb
Nektar Therapeutics
Synthorx
clinical trials
Lilly rejoins KRAS race with swipe at Amgen and Mirati, plans 2021 clinical trial
Fierce Biotech
Thu, 03/11/21 - 10:47 am
Eli Lilly
KRAS
Amgen
Mirati Therapeutics
LY3499446
solid tumors
Surface Oncology To Test SRF388 Plus Keytruda Combo In Solid Tumor Settings
Benzinga
Tue, 03/9/21 - 09:39 pm
Surface Oncology
Merck
Keytruda
SRF388
solid tumors
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »